Chairman emeritus TATA Sons, Ratan Tata invests in oncology firm

Q.  Which firm has Ratan Tata just invested in on 10th February 2016?
- Published on 10 Feb 16

a. Invictus Oncology Pvt Ltd
b. Tracxn
c. DogSpot
d. FirstCry

ANSWER: Invictus Oncology Pvt Ltd
 
Ratan Tata, the chairman emeritus of TATA Sons, has made the investment of a non disclosed amount in Delhi’s biopharma firm Invictus Oncology Pvt Ltd which is involved in uncovering cancer therapies. Invictus Oncology is the fifth firm Tata has invested in after Tracxn, DogSpot, FirstCry and CashKaro. This firm uses supramolecular technology platform for designing cancer treatment drugs. This company has also developed a deep pipeline of molecules tapping a USD 20 billion market opportunity in oncology space.

Related Content

➨ Post your comment / Share knowledge


Enter the code shown above:

(Note: If you cannot read the numbers in the above image, reload the page to generate a new one.)
▲